CN Patent
CN113750108A — 用于过重女性患者的基于屈螺酮的避孕药
Assigned to Laboratorios Leon Farma SA · Expires 2021-12-07 · 4y expired
What this patent protects
以至少3mg的含量包含于每日活性剂量单元中的屈螺酮作为唯一的避孕成分用作肥胖女性患者的避孕药的用途。
USPTO Abstract
以至少3mg的含量包含于每日活性剂量单元中的屈螺酮作为唯一的避孕成分用作肥胖女性患者的避孕药的用途。
Drugs covered by this patent
- Slynd (DROSPIRENONE) · Exeltis Usa Inc
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.